Breaking News

Daiichi Sankyo Acquires Amcor Facility

Daiichi Sankyo, Inc. (DSI) has acquired a 140,000 sq.-ft. facility in Bethlehem, PA from Amcor, in a transaction valued at $10.3 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Daiichi Sankyo, Inc. (DSI) has acquired a 140,000 sq.-ft. facility in Bethlehem, PA from Amcor, in a transaction valued at $10.3 million. The manufacturing and packaging facility allows DSI to use existing resources to more cost-effectively supplement its operations rather than build a new facility. Expected to be operational in the summer or fall of 2011, the facility is expected to package some of company’s marketed products, such as Benicar, Welchol and Azor. Once the facility is operating at full capacity, it is expected to assume responsibility for packaging the entire line of marketed products in the U.S., as well as perform compounding operations for select products.

DSI conducted a national site search with McCallum Sweeney Consulting to find an existing facility that met its packaging goals and specifications. Upon completing the initial phase of the renovation, DSI plans to hire approximately 80 new employees.

“This acquisition diversifies our company’s capabilities and allows us to streamline our operations and minimize commercialization risk by exerting greater control over the life cycle of our products, from research and development through packaging and distribution,” said Jeff Lane, vice president of operations, Daiichi Sankyo. “We are excited to be opening a facility in Bethlehem and look forward to a productive future working relationship and becoming a part of the local community.”
@font-face { font-family: “Cambria”; }@font-face { font-family: “Optima”; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: “Times New Roman”; }div.Section1 { page: Section1; }

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters